Loading...
c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met
PURPOSE: Strategies to inhibit the epidermal growth factor receptor (EGFR) using the tyrosine kinase inhibitor (TKI) erlotinib have been associated with limited clinical efficacy in head and neck squamous cell carcinoma (HNSCC). Co-activation of alternative kinases may contribute to erlotinib resist...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3549019/ https://ncbi.nlm.nih.gov/pubmed/23213056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1555 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|